Literature DB >> 4670495

Cephanone: in vitro antibacterial activity and pharmacology in normal human volunteers.

B R Meyers, S Z Hirschman, P Nicholas.   

Abstract

Cephanone, a new 3-heterocyclic-thiomethyl cephalosporin antibiotic, was found to have an antibacterial spectrum similar to that of cephalothin. The compound was active in vitro against a variety of gram-positive and gram-negative bacteria. All strains of Staphylococcus aureus tested were inhibited by concentrations of 6.2 mug or less of cephanone per ml. Beta-hemolytic group A streptococci and pneumococci were exquisitely sensitive. Among strains of Escherichia coli and Klebsiella sp., 83 and 82%, respectively, were inhibited by 3.1 mug or less of cephanone per ml. Excellent serum concentrations of the antibiotic were obtained after parenteral administration. Peak concentrations of 38 and 81.2 mug/ml were achieved in the serum after intramuscular and intravenous doses of 1 g of cephanone, respectively. The serum concentrations of cephanone fell gradually during the 12 hr after administration. Very high concentrations of cephanone were found in the urine.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4670495      PMCID: PMC444301          DOI: 10.1128/AAC.2.4.250

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  5 in total

1.  CEPHALOTHIN: ACTIVITY IN VITRO, ABSORPTION AND EXCRETION IN NORMAL SUBJECTS AND CLINICAL OBSERVATIONS IN 40 PATIENTS.

Authors:  J O KLEIN; T C EICKHOFF; J G TILLES; M FINLAND
Journal:  Am J Med Sci       Date:  1964-12       Impact factor: 2.378

2.  Cephapirin: pharmacology in normal human volunteers.

Authors:  J Axelrod; B R Meyers; S Z Hirschman
Journal:  J Clin Pharmacol New Drugs       Date:  1972 Feb-Mar

3.  Cephaloridine: antimicrobial activity and pharmacologic behavior.

Authors:  K Kaplan; B E Reisberg; L Weinstein
Journal:  Am J Med Sci       Date:  1967-06       Impact factor: 2.378

4.  Cephapirin: in vitro antibacterial spectrum.

Authors:  J Axelrod; B R Meyers; S Z Hirschman
Journal:  Appl Microbiol       Date:  1971-11

5.  Biological properties of three 3-heterocyclic-thiomethyl cephalosporin antibiotics.

Authors:  W E Wick; D A Preston
Journal:  Antimicrob Agents Chemother       Date:  1972-03       Impact factor: 5.191

  5 in total
  7 in total

1.  Pharmacological studies with cefamandole in human volunteers.

Authors:  B R Meyers; B Ribner; S Yancovitz; S Z Hirschman
Journal:  Antimicrob Agents Chemother       Date:  1976-01       Impact factor: 5.191

Review 2.  Newer beta-lactam antibiotics.

Authors:  J M Hamilton-Miller; W Brumfitt
Journal:  Infection       Date:  1974       Impact factor: 3.553

3.  In vitro studies with cephanone.

Authors:  S Shadomy; C Kirchoff; G Wagner
Journal:  Antimicrob Agents Chemother       Date:  1974-12       Impact factor: 5.191

4.  Comparative serum levels and protective activity of parenterally administered cephalosporins in experimental animals.

Authors:  L R Fare; P Actor; C Sachs; L Phillips; M Joloza; J F Pauls; J A Weisbach
Journal:  Antimicrob Agents Chemother       Date:  1974-08       Impact factor: 5.191

5.  Cefoxitin, a new semi-synthetic cephamycin: an in-vitro and in-vivo comparison with cephalothin.

Authors:  J Kosmidis; J M Hamilton-Miller; J N Gilchrist; D W Kerry; W Brumfitt
Journal:  Br Med J       Date:  1973-12-15

6.  Comparative activity of ampicillin and seven cephalosporins against group D streptococci.

Authors:  J M Hamilton-Miller
Journal:  J Clin Pathol       Date:  1974-10       Impact factor: 3.411

7.  Pharmacokinetics of cephanone in healthy adult volunteers.

Authors:  C Regamey; W M Kirby
Journal:  Antimicrob Agents Chemother       Date:  1973-12       Impact factor: 5.191

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.